All patients
non invasive oxygen
anti-inflammatory therapies in COVID-19 mild to moderate - Summary of results Outcome TE 95% CI n k I2 ROB Pub. bias death D28detailed results COL-COVID (Pascual-Figal), 2021 0.24 [0.01; 5.41]
0.24 [0.01 ; 5.41 ] COL-COVID (Pascual-Figal), 2021 1 0% 103 NA not evaluable deathsdetailed results COL-COVID (Pascual-Figal), 2021 0.24 [0.01; 5.41]
0.24 [0.01 ; 5.41 ] COL-COVID (Pascual-Figal), 2021 1 0% 103 NA not evaluable clinical deteriorationdetailed results COL-COVID (Pascual-Figal), 2021 0.38 [0.09; 1.58]
Ravichandran, 2021 0.02 [0.00; 0.36]
0.12 [0.01 ; 1.91 ] COL-COVID (Pascual-Figal), 2021, Ravichandran, 2021 2 69% 313 moderate not evaluable mechanical ventilationdetailed results COL-COVID (Pascual-Figal), 2021 0.24 [0.01; 5.41]
0.24 [0.01 ; 5.41 ] COL-COVID (Pascual-Figal), 2021 1 0% 103 NA not evaluable radiologic improvement (14-day)detailed results Rashad (CLARI vs SoC), 2021 2.87 [1.56; 5.28]
2.87 [1.56 ; 5.28 ] Rashad (CLARI vs SoC), 2021 1 0% 198 NA not evaluable viral clearance detailed results Ravichandran, 2021 1.71 [0.80; 3.64]
1.71 [0.80 ; 3.64 ] Ravichandran, 2021 1 0% 122 NA not evaluable viral clearance by day 7detailed results Ravichandran, 2021 1.71 [0.80; 3.64]
1.71 [0.80 ; 3.64 ] Ravichandran, 2021 1 0% 122 NA not evaluable ICU admissiondetailed results COL-COVID (Pascual-Figal), 2021 0.47 [0.08; 2.69]
0.47 [0.08 ; 2.69 ] COL-COVID (Pascual-Figal), 2021 1 0% 103 NA not evaluable serious adverse eventsdetailed results COL-COVID (Pascual-Figal), 2021 0.24 [0.01; 5.41]
0.24 [0.01 ; 5.41 ] COL-COVID (Pascual-Figal), 2021 1 0% 103 NA not evaluable adverse eventsdetailed results COL-COVID (Pascual-Figal), 2021 1.72 [0.73; 4.08]
Ravichandran, 2021 1.04 [0.02; 52.86]
1.68 [0.72 ; 3.91 ] COL-COVID (Pascual-Figal), 2021, Ravichandran, 2021 2 0% 313 moderate not evaluable 0.0 5.0 1.0 relative treatment effect www.metaEvidence.org 2024-09-25 14:18 +02:00
TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers);
k: number of studies; n: total number of patients;
ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1;
studied treatment is better when TE < 1;
pathologies: 90
- treatments: 564,944,682,1266,943,894,560,1102,598,563,668,753,752,836,639,541,534,581,615
- roots T: 290